Marius Drug Patent Portfolio
Marius owns 1 orange book drug protected by 6 US patents Given below is the list of Marius's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12403146 | 29 Mar, 2041 | Active | |
| US11617758 | Emulsion formulations | 15 Mar, 2033 | Active |
| US12357643 | 15 Mar, 2033 | Active | |
| US10576089 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
| US10576090 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
| US11590146 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols | 31 Dec, 2030 | Active |
Latest Legal Activities on Marius's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Marius.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 05 Sep, 2023 | US10576090 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 01 Sep, 2023 | US10576089 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 04 Apr, 2023 | US11617758 |
|
Recordation of Patent Grant Mailed
Critical
| 04 Apr, 2023 | US11617758 |
|
Email Notification
Critical
| 16 Mar, 2023 | US11617758 |
|
Issue Notification Mailed
Critical
| 15 Mar, 2023 | US11617758 |
|
Email Notification
Critical
| 28 Feb, 2023 | US11590146 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Feb, 2023 | US11590146 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Feb, 2023 | US11590146 |
|
Application Is Considered Ready for Issue
Critical
| 24 Feb, 2023 | US11617758 |
| Dispatch to FDC | 24 Feb, 2023 | US11617758 |
|
Issue Fee Payment Received
Critical
| 22 Feb, 2023 | US11617758 |
|
Issue Fee Payment Verified
Critical
| 22 Feb, 2023 | US11617758 |
|
Issue Notification Mailed
Critical
| 08 Feb, 2023 | US11590146 |
|
Application Is Considered Ready for Issue
Critical
| 31 Jan, 2023 | US11590146 |
Marius's Family Patents
Marius Drug List
Given below is the complete list of Marius's drugs and the patents protecting them.
1. Kyzatrex
Kyzatrex is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12403146 |
29 Mar, 2041
(15 years from now)
| Active | |
| US11617758 | Emulsion formulations |
15 Mar, 2033
(7 years from now)
| Active |
| US12357643 |
15 Mar, 2033
(7 years from now)
| Active | |
| US10576089 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(5 years from now)
| Active |
| US10576090 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(5 years from now)
| Active |
| US11590146 | Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols |
31 Dec, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Kyzatrex's drug page